Data as of 3:59pm ET
| -0.03 / -0.86%|
The 3 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +189.86% increase from the last price of 3.45.
The current consensus among 3 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.